
In its annual report for 2013, the company underlined its continued investment in R&D, which reached CNY 30.7 billion or 12.8 percent of revenue last year. Operating profit was still up, at CNY 29.1 billion versus CNY 20.7 billion in 2012, and net profit improved to CNY 21.0 billion from CNY 15.6 billion a year earlier.